Collection
MeSH Terms
Hemophilia B (C16.320.322.235); Hemophilia B (C16.320.099.510); Hemophilia B (C15.378.463.510); Hemophilia B (C15.378.100.141.510); Hemophilia B (C15.378.100.100.510); Hemophilia A (C16.320.099.500); Hemophilia A (C15.378.463.500); Hemophilia A (C15.378.100.141.500); Hemophilia A (C15.378.100.100.500); Factor XIII Deficiency (C15.378.100.100.335);von Willebrand Diseases (C15.378.100.100.900);Blood Coagulation Disorders; Inherited (C15.378.100.100)
Date for Review
n/a
Publication Date
03/08/2020
Date of Last Evidence Search
19-Nov
Methods Applied
Evidence-based & Trustworthy Consensus-Based Statement (TCBS); confidence in the panel composition and screening; systematic and comprehensive evidence searches; formal consensus achievement; transparency of data and methods throughout; rigorous review process.
Guideline Contact
Publication Scope
assessment
diagnosis
management
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
World Federation of Hemophilia
Willingness to Collaborate
Yes
Publication Year
2020